HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Botulinum toxin treatment of supranuclear ocular motility disorders.

Abstract
We treated one patient with bilateral internuclear ophthalmoplegia and another with skew deviation with extraocular muscle botulinum toxin injection. Both patients had pre-injection symptomatic diplopia in primary position, one for 1 month and the other for 12 months. Resolution of diplopia and complete and permanent binocular fusion in primary position was obtained within 3 to 4 days in both cases.
AuthorsN J Newman, S R Lambert
JournalNeurology (Neurology) Vol. 42 Issue 7 Pg. 1391-3 (Jul 1992) ISSN: 0028-3878 [Print] United States
PMID1620351 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Botulinum Toxins
Topics
  • Aged
  • Botulinum Toxins (therapeutic use)
  • Eye Movements (drug effects)
  • Female
  • Humans
  • Male
  • Ocular Motility Disorders (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: